[[link removed]]Taking on Big Pharma Monopolies to End the Pandemic featuring U.S. Reps. Rosa DeLauro and Jan Schakowsky
Wednesday, February 2nd, 12:00 PM - 1:00 PM ET
RSVP He re [[link removed]]We can end the pandemic, but it requires taking action now to break Big Pharma’s monopoly control of COVID-19 vaccines, diagnostic tests, and treatments. Absent a massive increase in the global production of these tools, we will face an endless cycle of new variants. Future mutations could be more lethal. And as we see with Omicron, extremely infectious variants of any lethality slam our hospitals and healthcare system and can leave millions suffering the disabling effects of long COVID-19.
The briefing will provide:
*
The
latest
on
the
dire,
ongoing
shortfall
in
global
COVID-19
vaccines,
tests
and
treatment
supplies;


*
The
status
of
negotiations
for
a
temporary
waiver
of
WTO
“TRIPS”
intellectual
property
monopolies
now
limiting
production
of
necessary
COVID-19
medications;
and


*
Summaries
of
key
papers
by
medical
school
professors
and
leading
public
health
scholars.
One
reveals
how
22
billion
doses
of
mRNA
vaccine
could
end
the
pandemic
and
one
way
to
produce
them
this
year.
Another
describes
the
100
facilities
globally
that
could
make
mRNA
vaccines
if
they
had
access
to
the
recipes.


RSVP Here [[link removed]]Introductory Remarks
Rosa DeLauro [[link removed]] , House Appropriations Chair, D-Conn
Jan Schakowsky [[link removed]] , House Consumer Protection Subcommittee Chair, D-Ill
Panel Discussion
Rita Kreynin [[link removed]] , MSF/Doctors Without Borders USA, Policy Officer
Achal Prabhala [[link removed]] , AccessIBSA, Coordinator
Garrett Wilkinson [[link removed]] , Partners In Health, Policy Officer
Moderated by Lori Wallach [[link removed]] , Director of Economic Liberties’ Rethink Trade
Wednesday, February 2nd
12:00 PM - 1:00 PM ET
RSVP Here [[link removed]][link removed] [[link removed]] [link removed] [[link removed]]

American Economic Liberties Project
1150 Connecticut Ave NW
Suite 800
Washington, DC 20036
United States
If you believe you received this message in error or wish to no longer receive email from us, please unsubscribe: [link removed] .